Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Giovanna Giarrè, Mario Franchini, Eleonora Castellacci, Maria Elena Malune, Attilio Di Spiezio Sardo, Gabriele Saccone & Stefano Angioni. (2020) Ulipristal acetate in symptomatic uterine fibroids. A real-world experience in a multicentric Italian study. Gynecological Endocrinology 36:2, pages 171-174.
Read now
Read now
Manuela Farris, Carlo Bastianelli, Elena Rosato, Ivo Brosens & Giuseppe Benagiano. (2019) Uterine fibroids: an update on current and emerging medical treatment options. Therapeutics and Clinical Risk Management 15, pages 157-178.
Read now
Read now
Raoul Orvieto, Eran Zilberberg, Valeria Stella Vanni & Amnom Botchan. (2018) A novel approach to infertility treatment of advance-age patient with prominent intramural fibroid. Gynecological Endocrinology 34:7, pages 551-553.
Read now
Read now
Articles from other publishers (19)
Veladanda Kavitha & Rachamalla Madhuri. (2021) Ulipristal Acetate Versus Leuprolide Acetate in Medical Management of Uterine Fibroids. Journal of Evolution of Medical and Dental Sciences 10:43, pages 3701-3706.
Crossref
Crossref
Emmanuel Ekanem & Vikram Talaulikar. (2020) Medical Therapy for Fibroids: What Next for Ulipristal Acetate?. Advances in Therapy 38:1, pages 137-148.
Crossref
Crossref
Somayye Arjeh, Fatemeh Darsareh, Zhila Abedi Asl & Maryam Azizi Kutenaei. (2020) Effect of oral consumption of vitamin D on uterine fibroids: A randomized clinical trial. Complementary Therapies in Clinical Practice 39, pages 101159.
Crossref
Crossref
E. N. Kareva & Т. Е. Samoylova. (2020) Uterine myoma: new and perspective options for medicinal treatment. Meditsinskiy sovet = Medical Council:3, pages 49-58.
Crossref
Crossref
Michal Ciebiera, Salvatore G. Vitale, Simone Ferrero, George A. Vilos, Fabio Barra, Salvatore Caruso, Antonio S. Laganà, Antoni Sierant, Antonio Cianci & Grzegorz Jakiel. (2020) Vilaprisan, a New Selective Progesterone Receptor Modulator in Uterine Fibroid Pharmacotherapy-Will it Really be a Breakthrough?. Current Pharmaceutical Design 26:3, pages 300-309.
Crossref
Crossref
Salvatore Giovanni Vitale, Simone Ferrero, Salvatore Caruso, Fabio Barra, Alejandro Marín-Buck, George Angelos Vilos, Amerigo Vitagliano, Péter Török, Michal Ciebiera & Antonio Cianci. (2020) Ulipristal Acetate Before Hysteroscopic Myomectomy: A Systematic Review. Obstetrical & Gynecological Survey 75:2, pages 127-135.
Crossref
Crossref
John Eden & Sheila O'Neill. (2019) The management of perimenopausal abnormal uterine bleeding. Obstetrics, Gynaecology & Reproductive Medicine 29:12, pages 359-363.
Crossref
Crossref
Mohamed Ghonim, Rana Magdy, Mohamed Sabbour, Mohanad Ghonim & Ashraf Nabhan. (2019) A systematic review and meta‐analysis of ulipristal acetate for symptomatic uterine fibroids. International Journal of Gynecology & Obstetrics 146:2, pages 141-148.
Crossref
Crossref
Rachel E. Zigler, Tessa Madden, Caitlin Ashby, Leping Wan & Colleen McNicholas. (2018) Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users. Obstetrics & Gynecology 132:4, pages 888-894.
Crossref
Crossref
Michał Ciebiera, Marta Włodarczyk, Magdalena Ciebiera, Kornelia Zaręba, Krzysztof Łukaszuk & Grzegorz Jakiel. (2018) Vitamin D and Uterine Fibroids—Review of the Literature and Novel Concepts. International Journal of Molecular Sciences 19:7, pages 2051.
Crossref
Crossref
Michał Ciebiera, Marta Włodarczyk, Małgorzata Wrzosek, Aneta Słabuszewska-Jóźwiak, Grażyna Nowicka & Grzegorz Jakiel. (2018) Ulipristal acetate decreases transforming growth factor β3 serum and tumor tissue concentrations in patients with uterine fibroids. Fertility and Sterility 109:3, pages 501-507.e2.
Crossref
Crossref
Jin-Jiao Li, Jacqueline P. W. Chung, Sha Wang, Tin-Chiu Li & Hua Duan. (2018) The Investigation and Management of Adenomyosis in Women Who Wish to Improve or Preserve Fertility. BioMed Research International 2018, pages 1-12.
Crossref
Crossref
Jeffrey M. Goldberg, Julian Gingold & Natalia Llarena. 2018. Recurrent Implantation Failure. Recurrent Implantation Failure
153
174
.
Mohamed Ali & Ayman Al-Hendy. (2017) Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids†. Biology of Reproduction 97:3, pages 337-352.
Crossref
Crossref
Serge Rozenberg, Julie Praet, Eliza Pazzaglia, Christine Gilles, Yannick Manigart & Jean Vandromme. (2017) The use of selective progestin receptor modulators (SPRMs) and more specifically ulipristal acetate in the practice of gynaecology. Australian and New Zealand Journal of Obstetrics and Gynaecology 57:4, pages 393-399.
Crossref
Crossref
Inge De Milliano, Dominique Van Hattum, Johannes C.F. Ket, Judith A.F. Huirne & Wouter J.K. Hehenkamp. (2017) Endometrial changes during ulipristal acetate use: A systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology 214, pages 56-64.
Crossref
Crossref
Ally Murji, Lucy Whitaker, Tiffany L Chow & Mara L Sobel. (2017) Selective progesterone receptor modulators (SPRMs) for uterine fibroids. Cochrane Database of Systematic Reviews 2017:4.
Crossref
Crossref
Mary Kern & Nicole S. Carlson. (2017) Current Resources for Evidence-Based Practice, March/April 2017. Journal of Obstetric, Gynecologic & Neonatal Nursing 46:2, pages e27-e36.
Crossref
Crossref
Michał Ciebiera, Marta Włodarczyk, Aneta Słabuszewska-Jóźwiak, Grażyna Nowicka & Grzegorz Jakiel. (2016) Influence of vitamin D and transforming growth factor β3 serum concentrations, obesity, and family history on the risk for uterine fibroids. Fertility and Sterility 106:7, pages 1787-1792.
Crossref
Crossref